Roos M H, Giles C M, Demant P, Mollenhauer E, Rittner C
J Immunol. 1984 Nov;133(5):2634-40.
The genetically determined polymorphism of the fourth component of human complement was further extended with the aid of a panel of human allo-anti-C4 sera, anti-Rodgers and anti-Chido. These antisera were found previously to react with the alpha-chains of the C4 molecules controlled by the C4A and C4B loci, respectively. We analyzed a number of new and rare C4 allotypes, and found that they generally followed the expected pattern. Some interesting exceptions, however, were found. The alpha-chain of the allotype C4A1 was found to react with anti-Chido, unlike all other C4A allotypes. Also the C4B5 allotype could be subdivided into two subtypes on the basis of their reaction with anti-Rodgers. They were tentatively named B5Rg+ and B5Rg-. Moreover, the B5Rg+ subtype reacted not only with anti-Rodgers but also with some anti-Chido sera, indicating for the first time that Chido and Rodgers determinants are present on the same allotype.
借助一组人同种异体抗C4血清(抗罗杰斯和抗奇多),人类补体第四成分的基因决定多态性得到了进一步扩展。先前发现这些抗血清分别与由C4A和C4B基因座控制的C4分子的α链发生反应。我们分析了许多新的和罕见的C4同种异型,发现它们总体上遵循预期模式。然而,也发现了一些有趣的例外情况。与所有其他C4A同种异型不同,发现同种异型C4A1的α链与抗奇多发生反应。此外,C4B5同种异型可根据其与抗罗杰斯的反应分为两个亚型。它们被暂时命名为B5Rg +和B5Rg-。此外,B5Rg +亚型不仅与抗罗杰斯反应,还与一些抗奇多血清反应,首次表明奇多和罗杰斯决定簇存在于同一同种异型上。